Thromb Haemost 1979; 41(03): 601-607
DOI: 10.1055/s-0038-1646813
Original Articles
Schattauer GmbH Stuttgart

Somatostatin-Induced Changes in the Hemostasis of Rats

Michael W Long
The Department of Physiology, Wayne State University School of Medicine and the Department of Research, Sinai Hospital of Detroit, Detroit, Michigan, U.S.A.
,
Piero Micossi
The Department of Physiology, Wayne State University School of Medicine and the Department of Research, Sinai Hospital of Detroit, Detroit, Michigan, U.S.A.
,
Antonio E Pontiroli
The Department of Physiology, Wayne State University School of Medicine and the Department of Research, Sinai Hospital of Detroit, Detroit, Michigan, U.S.A.
,
Joseph C Dunbar
The Department of Physiology, Wayne State University School of Medicine and the Department of Research, Sinai Hospital of Detroit, Detroit, Michigan, U.S.A.
,
Piero P Foà
The Department of Physiology, Wayne State University School of Medicine and the Department of Research, Sinai Hospital of Detroit, Detroit, Michigan, U.S.A.
,
Raymond L Henry
The Department of Physiology, Wayne State University School of Medicine and the Department of Research, Sinai Hospital of Detroit, Detroit, Michigan, U.S.A.
› Author Affiliations
Further Information

Publication History

Received 08 July 1978

Accepted 30 July 1978

Publication Date:
09 July 2018 (online)

Preview

Summary

Somatostatin (SRIF) given intravenously, either as a single bolus or as a 2 hr infusion caused a significant prolongation of partial thromboplastin time (PTT) and depressed platelet counts and platelet aggregation in the rat. Following daily injections of protamine- zinc SRIF for 2 weeks the platelet count returned to normal, PTT remained prolonged and platelet aggregation was enhanced. The doses of SRIF used in this work were adequate to suppress the secretion of insulin and glucagon by the isolated pancreatic islets of treated animals.